Moreover, the effects of various RhoA activities on the morphology, migration, and malignant features of ccRCC cells were evaluated in cells treated with Y27632 (a ROCK inhibitor) or cells overexpressing DN- and CARhoA. The gene discussed is RHOA; the disease is nonpapillary renal cell carcinoma.